ChemRar Research and Development Institute, LLC Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT04524975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ChemRar Research and Development Institute, LLC | "Research Center for Mental Health" Scientific Institution